Bright Minds Biosciences Inc

Research Bright Minds Biosciences Inc (DRUG) on Bullrun: market cap USD 678.80M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerDRUG
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 678.80M
• Financial periodQ1 2026
• Net income-USD 27.35M
• Free cash flow-USD 9.25M

Valuation Snapshot

latest market cap is USD 678.80M.

About Bright Minds Biosciences Inc

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies.

Frequently asked questions

What is Bright Minds Biosciences Inc's market cap?

Bright Minds Biosciences Inc's market capitalization is USD 678.80M.

What does Bright Minds Biosciences Inc do?

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders;